3 Infant Formula Stocks Advancing On ASX – A2M, BAL And WHA

The A2 Milk Company Limited (ASX: A2M)

The A2 Milk Company Limited (ASX: A2M) is currently having its operations in both the South and North Islands of New Zealand, in most states of Australia, in China, in the USA and the UK. On 22 November 2018, the shares of A2 Milk uplifted by 5.882% after the Chinese Government declared that it is planning to proceed and further enhance the current cross border e-commerce (CBEC) policy and its scope. In FY 2018, The Company’s financial results earned a Group Revenue of $922.7 million, a 68% increase over prior year; EBITDA of $283.0 million, double the previous year; Net Profit after tax of $195.7 million, up 116 percent on the last year; strong cash conversion with operating cash flow of $231.1 million, an increase of 131 percent; and importantly, record market share positions across all key products in all regions. In the last three months, the share price of the company decreased by 6.60 percent as on 22 October 2018. A2M’s shares traded at $9.760 with a market capitalization of circa $7.26 billion as on 23 November 2018.  [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

Bellamy’s Australia Limited (ASX: BAL)

In FY 2018, the Bellamy’s Australia Limited’s (ASX: BAL) Sales increased by 37% to $329 Mn and EBITDA increased by 65% to $71 Mn on a normalized basis and, in parallel, the company recorded a strong balance sheet with cash reserve of $88 Mn and debt-free status. The company is expecting a challenging trading environment in FY 2019 on the back of slower China cross-border growth across the category and stiff competition in terms of both availability and trade pricing for both local and global competitors. As per the company’s CEO, the sales in the first half of FY 2019 are expected to be 10-15% below than the first half of FY18 primarily due to an expected $10-15 million run-down of trade inventory prior to the rollout of the brand upgrade. However, Stronger performance is expected in the second half of FY 2019 as the company will return to normal trading and implement key revenue. In the last six months, the share price of the company decreased by 54.49 percent as on 22 November 2018, traded at a PE ratio of 19.260x. BAL’s shares traded at $7.270 with a market capitalization of circa $855.93 million as on 23 November 2018.

Wattle Health Australia Limited (ASX: WHA)

Wattle Health Australia Limited (ASX: WHA) is a provider of high quality, 100 percent Australian made health and wellness products. In FY 2018, the revenue of the company increased by 67.7% to $1.575 million as compared to last year. The gross profit of the company increased by 532% to $857,000 in FY 2018. The Net Tangible Assets (NTA) per ordinary security at the completion of FY18 was $0.31 per share compared to $0.065 for the corresponding period last year, an increase of 415%. During FY 2018, WHA delivered product to both Macau and the large and lucrative Indian market. The success in the Indian market resulted in WHA securing a 12-month supply agreement for its natural baby food range, valued at circa $1.5 million in sales. In the last six months, the share price of the company decreased by 38.35 percent as on 22 November 2018. WHA’s shares traded at $0.930 with a market capitalization of circa $181.86 million as on 23 November 2018.


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.



Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report